Stallergenes Greer : 1993-2010

#Success Story

17 années de détention
Création du leader mondial de l’immunothérapie allergénique
Chiffre d’affaires multiplié par 10
Cession à une société d’investissement familiale à forte spécialisation industrielle (Ares Life Sciences, fondée par la famille Bertarelli)
Multiple d’investissement de 35x
Montant investi par ̽��Ʒ: 12 millions d’euros

SUCCESS STORIES

40 ans

40 ans de croissance durable

Depuis 40 ans, ̽��Ʒaccompagne les sociétés sur le très long terme. Il arrive que sa détention soit de plus courte durée. Mais chaque décision est prise dans l’intérêt durable de l’entreprise. ̽��Ʒfavorise les acquisitions et les investissements industriels et porte une attention constante à l’innovation.

#Success Story

Allied Universal : 2015-2020

#Success Story

CSP Technologies : 2015-2018

#Success Story

Legrand : 2002-2013

#Success Story

Deutsch Group : 2006-2012

#Success Story

Editis : 2004-2008

#Success Story

bioMérieux : 1988 – 2007

#Success Story

Capgemini : 1982-2006

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN

This announcement does not, and shall not, in any circumstances constitute a public offering, nor an offer to sell or to subscribe, nor a solicitation to offer to purchase or to subscribe securities in any jurisdiction. I therefore certify that:

I am a resident of a country or jurisdiction where I am qualified or authorized to have access to the information and documents presented on this site;

I am not a resident of or physically present in the United States of America, Canada, Australia or Japan;

I have read and understand, and agree to comply with, the terms and conditions described above and that I am eligible to access the press release in accordance with such terms and conditions.

I have read and understand the foregoing, and hereby make the certifications above and agree to comply with all of the above restrictions:

IMPORTANT INFORMATION

Access to the information and documents on this portion of the website is restricted for regulatory reasons.

You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.

Please enter your country of residence :

IMPORTANT INFORMATION

The materials contained herein are not for general release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Australia, Japan, Canada or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.

The information contained in this section of the website of ̽��Ʒ(the “Seller”) (a) is only intended for, and may only be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident and physically present outside the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the “United States”), Australia, Canada, or Japan, and resident and physically present in a jurisdiction where to do so will not constitute a violation of the local securities laws or regulations of such jurisdiction, and (b) does not constitute an offer to sell or the solicitation of an offer to buy or acquire any securities of the Bureau Veritas (the “Company”) in the United States, Australia, Canada, Japan, or any other jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

The securities of the Company referred to in this section of the website (the “Securities”) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or with any securities regulatory authority of any state of the United States for offer or sale as part of their distribution and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. The Securities have not been and will not be registered under the applicable securities laws of Australia, Canada or Japan, or any other jurisdiction in which it would be unlawful or would require registration or other measures, and therefore may not be offered or sold to or for the account or benefit of any person having a registered address in, or located or resident in, Australia, Canada, Japan or any other jurisdiction in which it would be unlawful or would require registration or other measures.

Access to the information contained on this portion of the website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons who wish to have access to the documents contained in this section of the Seller’s website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been or will be obtained. The Seller assumes no responsibility if there is a violation of applicable law and regulations by any person.

If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

I therefore certify that:

I am resident and physically present in a country outside the United States, Australia, Canada and Japan;

I am authorized to access the information and documents contained on this portion of the website without being subject to any legal restriction and without any further action required by the Seller;

I will not transmit or otherwise send any information contained in this website to publications with a general circulation in the United States; and

I have read, understand and agree to comply with all of the restrictions set forth above.

DISCLAIMER – IMPORTANT

Due to applicable legal restrictions, the information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Australia, Canada or Japan, or any other jurisdiction in which such release, publication or distribution would be unlawful. We apologize for any inconvenience this may cause.

̽����Ʒ